Search details
1.
A-loop interactions in Mer tyrosine kinase give rise to inhibitors with two-step mechanism and long residence time of binding.
Biochem J
; 477(22): 4443-4452, 2020 11 27.
Article
in English
| MEDLINE | ID: mdl-33119085
2.
Tool inhibitors and assays to interrogate the biology of the TRAF2 and NCK interacting kinase.
Bioorg Med Chem Lett
; 29(15): 1962-1967, 2019 08 01.
Article
in English
| MEDLINE | ID: mdl-31153805
3.
G6b-B antibody-based cis-acting platelet receptor inhibitors (CAPRIs) as a new family of anti-thrombotic therapeutics.
bioRxiv
; 2024 May 14.
Article
in English
| MEDLINE | ID: mdl-38798354
4.
Generating Selective Leads for Mer Kinase Inhibitors-Example of a Comprehensive Lead-Generation Strategy.
J Med Chem
; 64(6): 3165-3184, 2021 03 25.
Article
in English
| MEDLINE | ID: mdl-33683117
5.
Heparan sulfates are critical regulators of the inhibitory megakaryocyte-platelet receptor G6b-B.
Elife
; 82019 08 22.
Article
in English
| MEDLINE | ID: mdl-31436532
6.
The Use of Antibodies in Small-Molecule Drug Discovery.
J Biomol Screen
; 19(6): 829-38, 2014 Jul.
Article
in English
| MEDLINE | ID: mdl-24695620
7.
Validation of the BRCA1 antibody MS110 and the utility of BRCA1 as a patient selection biomarker in immunohistochemical analysis of breast and ovarian tumours.
Virchows Arch
; 462(3): 269-79, 2013 Mar.
Article
in English
| MEDLINE | ID: mdl-23354597
Results
1 -
7
de 7
1
Next >
>>